Stay updated on COMBI-i Clinical Trial: Anti-PD1 + Dabrafenib/Trametinib
Sign up to get notified when there's something new on the COMBI-i Clinical Trial: Anti-PD1 + Dabrafenib/Trametinib page.

Latest updates to the COMBI-i Clinical Trial: Anti-PD1 + Dabrafenib/Trametinib page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe study's recruitment status was updated to No longer looking for participants, indicating recruitment has ceased. A new Revision: v3.6.0 entry has been added, replacing the previous Revision: v3.5.5.SummaryDifference0.2%

- Check18 days agoChange DetectedA new revision entry, v3.5.5, was added to the Study Record History, replacing the previous v3.5.4. This reflects an administrative update to the page rather than changes to the trial data.SummaryDifference0.0%

- Check39 days agoChange DetectedNew site revision tag appears: Revision: v3.5.4 has been added, replacing Revision: v3.5.3. This indicates a routine upgrade to the site's underlying version.SummaryDifference0.0%

- Check61 days agoChange DetectedThe page’s displayed interface revision/version is updated from v3.5.2 to v3.5.3, indicating a system release on ClinicalTrials.gov rather than a change to the trial’s record history.SummaryDifference0.0%

- Check68 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0 in the study history.SummaryDifference0.0%

- Check97 days agoChange DetectedAdded revision v3.5.0 to the history and removed revision v3.4.3.SummaryDifference0.0%

Stay in the know with updates to COMBI-i Clinical Trial: Anti-PD1 + Dabrafenib/Trametinib
Enter your email address, and we'll notify you when there's something new on the COMBI-i Clinical Trial: Anti-PD1 + Dabrafenib/Trametinib page.